-
Product Insights
NewAdvanced Accelerator Applications SA Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Advanced Accelerator Applications SA Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company develops new medicines which targets the orphan diseases in the field of cardiology, oncology, neurology and inflammation. It is also involved in manufacturing Positron Emission tomography (PET) and single-photon emission computed tomography (SPECT). It’s...
-
Innovation Ranking
Innovation Ranking – Accelerate Diagnostics Inc
Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company engaged in the development and commercialization of instruments for the identification and testing of antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, a platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit, which provides ID and AST results for patients with bacteremia or fungemia. It operates a manufacturing facility in Tucson, Arizona. The company sells products directly...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ponatinib Hydrochloride in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ponatinib Hydrochloride in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ponatinib Hydrochloride in Acute Myelocytic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RGT-075 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RGT-075 in Obesity report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RGT-075 in Obesity Drug Details: RGT-075 is under development for the treatment...
-
Sector Analysis
NewRadiosurgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Radiosurgery Systems Market Report Overview The Radiosurgery Systems market size was valued at $618.8 million in 2023 and will grow at a CAGR of more than 3% during 2023-2033. Radiosurgery Systems utilize beams to deliver a focused dose of radiation to a targeted tumor. Radiosurgery Systems Market Outlook 2023-2023 ($ Million) Buy Full Report for More Insights on the Radiosurgery Systems Market Forecast Download a Free Sample Report The Radiosurgery Systems market research report identifies quantitative market trends within cardiovascular...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-813160 in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-813160 in Metastatic Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMS-813160 in Metastatic Pancreatic Cancer Drug Details: BMS-813160 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-813160 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-813160 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMS-813160 in Solid Tumor Drug Details: BMS-813160 is under development for...
-
Company Insights
NewDecoding Microsoft’s YouTube Advertising Strategy in Q1 2024
The report on Microsoft's advertising strategies on YouTube during the first quarter of 2024, focuses on key products such as Microsoft Copilot and its integration with post meeting recaps and PowerPoint presentations, followed by collaboration between Microsoft Azure Quantum and PNNL. It analyzes the core themes, messaging strategies, and product benefits portrayed in these advertisements, highlighting elements such as AI Integration, Time Management, Personalization and Collaboration. Moreover, the report examines the overarching themes of Innovation, Efficiency, Sustainability and Empowerment infused...
-
Company Insights
NewLVMH Moet Hennessy Louis Vuitton SE – Digital Transformation Strategies
This report provides insights into LVMH's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.